Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.

IF 4.5 2区医学 Q1 ONCOLOGY Lung Cancer Pub Date : 2025-01-02 DOI:10.1016/j.lungcan.2024.108076

Stephanie P L Saw, Wen-Zhao Zhong, Rui Fu, Molly S C Li, Yasushi Goto, Stephen B Fox, Yasushi Yatabe, Boon-Hean Ong, Calvin S H Ng, David D W Lee, Pham Cam Phuong, In Kyu Park, James C H Yang, Masahiro Tsuboi, Lye Mun Tho, Thomas John, Hsao-Hsun Hsu, Daniel S W Tan, Tony S K Mok, Thanyanan Reungwetwattana, Navneet Singh

{"title":"Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.","authors":"Stephanie P L Saw, Wen-Zhao Zhong, Rui Fu, Molly S C Li, Yasushi Goto, Stephen B Fox, Yasushi Yatabe, Boon-Hean Ong, Calvin S H Ng, David D W Lee, Pham Cam Phuong, In Kyu Park, James C H Yang, Masahiro Tsuboi, Lye Mun Tho, Thomas John, Hsao-Hsun Hsu, Daniel S W Tan, Tony S K Mok, Thanyanan Reungwetwattana, Navneet Singh","doi":"10.1016/j.lungcan.2024.108076","DOIUrl":null,"url":null,"abstract":"<p><p>The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.</p>","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"200 ","pages":"108076"},"PeriodicalIF":4.5000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.lungcan.2024.108076","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

亚洲胸肿瘤研究小组关于非小细胞肺癌围手术期治疗的专家共识声明。

近年来，随着免疫检查点抑制剂和靶向治疗的结合，早期非小细胞肺癌（NSCLC）的围手术期治疗取得了重大进展。然而，许多未解决的问题和挑战仍然存在，包括临床试验数据在常规临床实践中的应用。认识到亚洲非小细胞肺癌患者独特的人口统计学特征和不同的医疗保健系统，亚洲胸部肿瘤研究小组（ATORG）于2024年4月26日在新加坡召开了一次共识会议，讨论从诊断测试到新辅助治疗后考虑和未来方向的相关问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lung Cancer 医学-呼吸系统

CiteScore

9.40

自引率

3.80%

发文量

407

审稿时长

25 days

期刊介绍： Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.